Emerging data from the UK are generating considerable buzz surrounding the potential pairing of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unusual approach https://retatrutide20mguk538786.bloghins.com/148509/the-nad-1000mg-retatrutide-a-uk-advance-in-metabolic-health